{"name":"Pathway Therapeutics, Inc.","slug":"pathway-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPbUtuenNqQmFBdHE0UHg3ZWk3WVI0U3dRbkZJZENMN3NtRmQ4UVpvZmJWd1puNURIeFZiQUtvNFpsRDB2d0VSUkpGekpGV0hHelVxejMzNTZBZ0RpTF9PZHY0VjJ5WHp6M0ZqU3l6ZnNXbmx6SlJLUXE3V1F0ODhSc0lPdXA2cXR0ZWdyRTA2UFkxY0lJX0pySW9CX1lfRzNVRjl1SV9TMTlWa2tTNGRYakNoNjQxTnpka0NEM3EwbnZQZDh4ZWVnb3dtQ3dtUTNnVWx1Wk9CcFdTcjVxbE5FZXhNUXgtcUwycFE?oc=5","date":"2026-04-06","type":"regulatory","source":"Quiver Quantitative","summary":"Silo Pharma Secures European Patent Approval for Preventative Therapy Targeting 5-HT4 Pathway in Stress-Related Disorders - Quiver Quantitative","headline":"Silo Pharma Secures European Patent Approval for Preventative Therapy Targeting 5-HT4 Pathway in Stress-Related Disorder","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2026-03-30","type":"pipeline","source":"simplywall.st","summary":"AI-Enabled ATTR-CM Care Pathway Initiative Might Change The Case For Investing In Alnylam Pharmaceuticals (ALNY) - simplywall.st","headline":"AI-Enabled ATTR-CM Care Pathway Initiative Might Change The Case For Investing In Alnylam Pharmaceuticals (ALNY)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxOdVJYSFlfSU9NSS03VzBlSXJ2YmRrN2NVSmhfR3pHUHR4SlFIOHNXVkU2ZUI3NDJGWU1Ba0JkY2VKSFdtY3F3MUNOckVmS1RWUWo2UDZ1VTh4ZXVXejNETHdwU192Z3BnXzU4RWx4UXBwcWxpNjl3VGx3d0c3U0Jlc1E0bUtiT0VKYThiNjE0b2JpQW04VWJhbUgxaWpVUG9Yd0M2X3ctRzNxUk90aDhpR0FPaHVMaS1fOVVJUE1CbENSZXRVYW9tNlNvdlpxdE9EYzhMZnQzNUhDaTVjTWt2aHVOMmlHZE9jeU1fWnQyemtVQQ?oc=5","date":"2026-03-17","type":"trial","source":"businesswire.com","summary":"Onchilles Pharma to Present New Preclinical Data on Systemically Delivered NEU-002 Program at AACR 2026 - businesswire.com","headline":"Onchilles Pharma to Present New Preclinical Data on Systemically Delivered NEU-002 Program at AACR 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPUXRBYVdMb29hZXVveTl1MmFPU0VEaXdtR2t2T2hMdldOU2hxSWdEY0RiS05MajhTRGhUVHhNUzU4WC1leGtIY2VkVlF4OFdDZ2RyR1dtNFdIdHBlSG5KUm9aTWdxRGV0LUpsOVJmY1ZOdnpBWFN0U0NfcGFCMlV2ZE5BaExCbzM4M1ZBQ3BiQUNrWGVsbWhMYzF0NGFsdFkzWEg3cw?oc=5","date":"2026-03-09","type":"regulatory","source":"Investing News Network","summary":"CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions - Investing News Network","headline":"CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQWHdOd096aUMyZ09jQk05VXJsalpGTC1LRTNIWW44Zk8zcU1NQlJqMHc3ZjZLd0hFOS1jbXZMTVJwY2h4SlFxbVJGZEFkMkl5WDEzOE9QV2NqazFhS05tbGtfSFozbXo0Z0RLSGdMRVJlbTU0Q1gwYjNfR2dvSWRlVEhYaEJiWDl1TjNKelk2a2o5eXFHbjlPSG5QclNmMThYb1NZ?oc=5","date":"2026-02-20","type":"regulatory","source":"BioWorld News","summary":"Japan endorses two iPSC drugs for approval under CEA pathway - BioWorld News","headline":"Japan endorses two iPSC drugs for approval under CEA pathway","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQSG1Lb1d5Nk54Z0dlOU1JMUR5VmpycURvVXZjajlCTFgwb3g2bV9tcmloZ1A1aF9IWTlZMDhfZThvcjZfNjJjVngyWWRnQmJ6SXJiWUprSWlSUTVQVm5CNFlTQlhmRFRFb2ZERDAzQnBkcklTblNsenAyTGtMTzA5MFlTckJvLUI5NnJfY2YzMm9rblU0UGQ4a1N5aDQ3T0ZxMFNHdWJRRXhTeE5Wbkt1UGp1M0tad0I3dFotYmtR?oc=5","date":"2026-02-19","type":"regulatory","source":"Seeking Alpha","summary":"Catalyst Pharmaceuticals: Clear Path Forward For Growth In 2 FDA-Approved Drugs (CPRX) - Seeking Alpha","headline":"Catalyst Pharmaceuticals: Clear Path Forward For Growth In 2 FDA-Approved Drugs (CPRX)","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQWktmeS1yRVU0cEV4Wmg3UFFzWHpqdG81blc2U0JjeUdrTmRETW9wOEJqUUQ2ZnhMVjlza1AwNGUyaEpZYm1YM0hBUTVWdlFMbTBpbUhCeXlJTVpldEFGVnAyQnAyUUhIV0o0V3BWUFdydUpraWJpNi14SkY4SFVmZU1xQTBtdGFKWE4yd09fSy1XY1o0M0g3czZ0RQ?oc=5","date":"2026-02-16","type":"regulatory","source":"Yahoo Finance","summary":"Zentalis Pharmaceuticals Details Azenosertib Path to PROC Approval, DENALI Dose Pick Coming Soon - Yahoo Finance","headline":"Zentalis Pharmaceuticals Details Azenosertib Path to PROC Approval, DENALI Dose Pick Coming Soon","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxPbktSejEtdVh5MFhOeGFuZ1JfcF9ubG1oVk9Hai00RDQ4NXZRcE5lMFJjMXhWSlZVVUdZZl8wZzlqOXYtZEJqWkxTbi1NMWpJVHJ6enU2ZHRRSVFqVjVSYWZhbFJUdVVsakVXSFVna1VjQ0x2WnpBOVFSbWhYai1XUzhLTHc2WUZrVGFvUVVmUU9sMmpBdExhcTdfRUFKTjBic3h6RGwzSEFRbTlrcFlnTk1aYTBxTDZlbThuaGgwZ01lZzdSLVNtYXowaTFEUjhQTGtyY0s1ZmhfN3lzRHM3VF9kQWY3Z3plbDVoUEE1Q0pQbEx0N2Q4dzhHMFFSSDJwckFlUzBlcEVIY0NSXy1tWTVESkxBVWdPRmJ5OFNDYkp3WkpfUVFGNl9Ua0JjSVFKYlJ6ZXNB?oc=5","date":"2026-02-02","type":"pipeline","source":"businesswire.com","summary":"Onchilles Pharma Announces IND Clearance for N17350, Advancing the First Next-Generation Cytotoxic Therapeutic Leveraging the ELANE Pathway into the Clinic - businesswire.com","headline":"Onchilles Pharma Announces IND Clearance for N17350, Advancing the First Next-Generation Cytotoxic Therapeutic Leveragin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNSmRGcldNVTVndTdDZHpaU3hjTm43TXdtd05DeGxJVVgta1I5RUJXQlBUTjNrWE9YR2ZVMmhqc05aVkwyNmEySTNYeXJXQ2JiSlhiN2N5SklCdFkxZEs1YmE4alJ0WjBROWY4cXFPWjVac3RRNmk3U1E4LU5TWVZ3TlpieENOcU9JQVJzNzdydHpWNEtjU3hyNHhKVzBhOG9UaVEzaFdqQWdxOXBfbExsTHhCQjFpZUMyY2hmbjNB?oc=5","date":"2025-12-09","type":"deal","source":"Contract Pharma","summary":"Bora Pharmaceuticals, Corealis Pharma Partner to Provide OSD Services - Contract Pharma","headline":"Bora Pharmaceuticals, Corealis Pharma Partner to Provide OSD Services","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPNEpYTEk0R0psRlhvUGdDMG1Fa2ZxYmVBSUsxTkc5aEFpeGtSQjRVb1F1QmpxMjZjT1JiYXV5cXpqel9oTl83TDZ1b2lrVmV3SXVqS3ZfQTI4MWktUXBIa2pUYXR2bElvazFvU3hfYTJuZHczdHVqVXRoNWlReHExcUhJTGZpMEVsdnNtSm04SFZkMno3NVZGejJFcWp2V2xxZWFRTkphTzNoTE9CODZXTnBCaS1EWVFPVWRfS3Z3cGxsaklwbWdUXw?oc=5","date":"2025-11-13","type":"regulatory","source":"Reuters","summary":"US FDA unveils new pathway to approve personalized therapies - Reuters","headline":"US FDA unveils new pathway to approve personalized therapies","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxOeENBdUV1SW5jekd5X3I3VkNQaDVvZFdhdWhkQm14V0pMaGxGdVdPSmczX05rUjhZWGUtQ0Q5a09vY3FtRkZFeU1sclREeEl1NjhSV2VTRTV3U2dXQlktUGt6a0dMb0w4ZDI0ZXNjdTdqeDVMX0lYdFo2M0diSmdHVmVJUzItdzltVERQU3lTa0pEUnZfNnRVdC05Z1IzUmdZRmVUaVh6YkxtanotendrSVhLbmRCUVZWc3pZMWpuMUdNNmlrUktqTDZ0b0RJNGVTRklYLUNEQWpZWHJmR1RNdDVjak1rdmpyZEMyM0twV2otXzBudTh1VjA0ZG5OUkY4eDZQZ0FYNExVa2xMUGc?oc=5","date":"2025-11-10","type":"trial","source":"BioSpace","summary":"Onchilles Pharma Publishes Landmark ELANE Pathway Study and Advances N17350 Toward the Clinic With New Financing and Leading Clinical Advisor - BioSpace","headline":"Onchilles Pharma Publishes Landmark ELANE Pathway Study and Advances N17350 Toward the Clinic With New Financing and Lea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNU2dUcUFYQVhNUFhfeUR4WTNSRXdMUU5HcDNuWGdRREV0dlZqZzJzRjNGSTl3VjktQlZSd0JBM3luaFRzb0k5RTd6cm0xc1RPbzE4TklXQ0pia3JHd3ZnSG94N2lNZEcxTlRBQmNDYlhGQTNGZVhJSUdmZkZGY3BiSlRwYms3VDBoSmhoQWNSNHhhVENST2dQSE5rVThka2NXQk1OWldUeVAxUQ?oc=5","date":"2025-11-07","type":"pipeline","source":"Drug Discovery News","summary":"Experimental therapy uses innate immunity to fight diverse cancers - Drug Discovery News","headline":"Experimental therapy uses innate immunity to fight diverse cancers","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}